Cite
Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era.
MLA
Saba, Nabil F., et al. “Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era.” Cancers, vol. 14, no. 5, Mar. 2022, p. 1202. EBSCOhost, https://doi.org/10.3390/cancers14051202.
APA
Saba, N. F., Vijayvargiya, P., Vermorken, J. B., Rodrigo, J. P., Willems, S. M., Zidar, N., de Bree, R., Mäkitie, A., Wolf, G. T., Argiris, A., Teng, Y., & Ferlito, A. (2022). Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era. Cancers, 14(5), 1202. https://doi.org/10.3390/cancers14051202
Chicago
Saba, Nabil F., Pooja Vijayvargiya, Jan B. Vermorken, Juan P. Rodrigo, Stefan M. Willems, Nina Zidar, Remco de Bree, et al. 2022. “Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era.” Cancers 14 (5): 1202. doi:10.3390/cancers14051202.